The expression of hexokinase 2 (HK2) in metabolic dysfunction-linked steatohepatitis (MASLD) represents a connection between elevation in glycolytic flux and lactate production, which triggers IL-10 expression together with NF-κB signalling via H3K18la-promoting chromatin opening. Here, HK2 is linked to metabolic dysfunction-associated steatotic liver disease.